Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Wigzell Hans Lennart Rudolf
Director at Sarepta Therapeutics. Filing since 30 Nov 2017.
CIK 0001492766
Company
Date
Role
Action
Shares
Amount
Of holding
SRPT
Sarepta Therapeutics, Inc.
12 Dec 2024
Director
Sold at will
10,500
$1.31M
31.5%
SRPT
Sarepta Therapeutics, Inc.
8 Mar 2024
Director
Sold at will
15,000
$1.85M
39.6%
SRPT
Sarepta Therapeutics, Inc.
4 Aug 2023
Director
Sold at will
15,000
$1.60M
41.7%
SRPT
Sarepta Therapeutics, Inc.
8 Mar 2021
Director
Sold, plan not stated
10,000
$835.10K
37.7%
SRPT
Sarepta Therapeutics, Inc.
10 Aug 2020
Director
Sold, plan not stated
10,000
$1.59M
42.0%
SRPT
Sarepta Therapeutics, Inc.
20 May 2020
Director
Sold, plan not stated
5,000
$753.21K
26.6%
SRPT
Sarepta Therapeutics, Inc.
4 Mar 2020
Director
Sold, plan not stated
5,000
$584.45K
26.6%
SRPT
Sarepta Therapeutics, Inc.
23 May 2019
Director
Sold, plan not stated
10,000
$1.20M
46.0%
SRPT
Sarepta Therapeutics, Inc.
1 Nov 2018
Director
Sold, plan not stated
6,667
$936.71K
39.8%
SRPT
Sarepta Therapeutics, Inc.
30 Nov 2017
Director
Sold, plan not stated
6,667
$372.62K
50.0%
10 decisions on file.
